(Q38333573)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25623915%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

review article

1 reference

title

Surgery in the treatment of type 2 diabetes mellitus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25623915%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25623915%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

author name string

A Maleckas

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25623915%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

L Venclauskas

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25623915%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

H Lönroth

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25623915%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

L Fändriks

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25623915%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

publication date

26 January 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25623915%20AND%20SRC:MED&resulttype=core&format=json

Scandinavian Journal of Surgery

28 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25623915%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

volume

104

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25623915%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25623915%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

page(s)

40-47

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25623915%20AND%20SRC:MED&resulttype=core&format=json

Diabetes epidemiology as a tool to trigger diabetes research and care

28 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Weight gain as a risk factor for clinical diabetes mellitus in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Effects of intensive glucose lowering in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Glycaemic separation and risk factor control in the Veterans Affairs Diabetes Trial: an interim report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Severe hypoglycemia and risks of vascular events and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Ethnic comparisons of the cross-sectional relationships between measures of body size with diabetes and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Effects of anti-obesity drugs, diet, and exercise on weight-loss maintenance after a very-low-calorie diet or low-calorie diet: a systematic review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Diabetes and weight in comparative studies of bariatric surgery vs conventional medical therapy: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

How do we define cure of diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Effect of the definition of type II diabetes remission in the evaluation of bariatric surgery for metabolic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Bariatric surgery versus conventional medical therapy for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Bariatric surgery versus intensive medical therapy in obese patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Standards of medical care in diabetes--2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Nationwide cohort study of post-gastric bypass hypoglycaemia including 5,040 patients undergoing surgery for obesity in 1986-2006 in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Advances in the etiology and management of hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Long-term nutritional outcome after gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

A multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Analysis of factors associated with durable remission of diabetes after Roux-en-Y gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Cardiovascular events after bariatric surgery in obese subjects with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Long term predictors of success after laparoscopic sleeve gastrectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

The effects of biliopancreatic diversion on type 2 diabetes mellitus in patients with mild obesity (BMI 30-35 kg/m2) and simple overweight (BMI 25-30 kg/m2): a prospective controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Metabolic effects of bariatric surgery in patients with moderate obesity and type 2 diabetes: analysis of a randomized control trial comparing surgery with intensive medical treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Roux-en-Y gastric bypass vs sleeve gastrectomy for obese patients with type 2 diabetes: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Comparison of laparoscopic Roux-en-Y gastric bypass with laparoscopic sleeve gastrectomy for morbid obesity or type 2 diabetes mellitus: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Effect of Roux-en-Y gastric bypass vs sleeve gastrectomy on glucose and gut hormones: a prospective randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Single anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S). One to three-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Lower glycemic fluctuations early after bariatric surgery partially explained by caloric restriction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Biliopancreatic diversion with duodenal switch improves insulin sensitivity and secretion through caloric restriction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Remission of type 2 diabetes after gastric bypass and banding: mechanisms and 2 year outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Changes in glucagon-like peptide-1 (GLP-1) secretion after biliopancreatic diversion or vertical banded gastroplasty in obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Ileal [correction of ilial] transposition and enteroglucagon/GLP-1 in obesity (and diabetic?) surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Ileal interposition surgery improves glucose and lipid metabolism and delays diabetes onset in the UCD-T2DM rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Early improvement of glucose tolerance after ileal transposition in a non-obese type 2 diabetes rat model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Endoscopic interventions for weight loss surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Endoscopic duodenal-jejunal bypass liner rapidly improves type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Metabolic improvements in obese type 2 diabetes subjects implanted for 1 year with an endoscopically deployed duodenal-jejunal bypass liner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

A novel function of intestinal gluconeogenesis: central signaling in glucose and energy homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Intestinal gluconeogenesis is a key factor for early metabolic changes after gastric bypass but not after gastric lap-band in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Colesevelam HCl improves glycemic control and reduces LDL cholesterol in patients with inadequately controlled type 2 diabetes on sulfonylurea-based therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Bile acids and gut peptide secretion after bariatric surgery: a 1-year prospective randomized pilot trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Functional food science and gastrointestinal physiology and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Microbial ecology: human gut microbes associated with obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Human gut microbiota in obesity and after gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Glucose metabolism: focus on gut microbiota, the endocannabinoid system and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Impaired glucose tolerance. Why is it not a disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Effects of bariatric surgery on diabetic nephropathy after 5 years of follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1457496914561140

Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus

21 January 2018

1 reference

COCI

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD008143.PUB2

12 January 2024

Identifiers

DOI

10.1177/1457496914561140

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25623915%20AND%20SRC:MED&resulttype=core&format=json

release_jlm3ppjqhjabfn7vi3wvwrrisi

28 February 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jlm3ppjqhjabfn7vi3wvwrrisi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25623915%20AND%20SRC:MED&resulttype=core&format=json